(Q84510970)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21732045%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Long-term therapy with intravenous immunoglobulin is beneficial in patients with autoimmune diseases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21732045%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

4

Pnina Langevitz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21732045%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Gisele Zandman-Goddard

series ordinal

1

object named as

Gisele Zandman-Goddard

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21732045%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

5

Yehuda Shoenfeld

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21732045%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Alexander Krauthammer

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21732045%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Yair Levy

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21732045%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

1 April 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21732045%20AND%20SRC:MED&resulttype=core&format=json

Clinical Reviews in Allergy & Immunology

6 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21732045%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21732045%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21732045%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

247-255

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21732045%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12016-011-8278-7

6 February 2020

exact match

0 references

cites work

EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases

1 reference

12 December 2020

Phosphorylcholine: friend or foe of the immune system?

1 reference

12 December 2020

The role of IVIg treatment in severe pemphigus vulgaris.

1 reference

12 December 2020

Adverse effects of intravenous immunoglobulin therapy in 56 patients with autoimmune diseases

1 reference

12 December 2020

1 reference

12 December 2020

Intravenous immunoglobulin - indications and mechanisms in cardiovascular diseases

1 reference

12 December 2020

Safety of intravenous immunoglobulin (IVIG) therapy

1 reference

12 December 2020

In vivo enzymatic modulation of IgG glycosylation inhibits autoimmune disease in an IgG subclass-dependent manner

1 reference

12 December 2020

Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin

1 reference

12 December 2020

Efficacy of IVIG affinity-purified anti-double-stranded DNA anti-idiotypic antibodies in the treatment of an experimental murine model of systemic lupus erythematosus

1 reference

12 December 2020

Intravenous immunoglobulins in systemic lupus erythematosus: from the bench to the bedside

1 reference

12 December 2020

The efficacy of specific IVIG anti-idiotypic antibodies in antiphospholipid syndrome (APS): trophoblast invasiveness and APS animal model

1 reference

12 December 2020

Intravenous immunoglobulin and the kidney--a two-edged sword

1 reference

12 December 2020

Therapeutic and prognostic considerations in catastrophic antiphospholipid syndrome

1 reference

12 December 2020

The antiinflammatory IgG.

1 reference

12 December 2020

Evidence for the use of intravenous immunoglobulins--a review of the literature

1 reference

12 December 2020

Acute myocardial infarction associated with high dose intravenous immunoglobulin infusion for autoimmune disorders. A study of four cases.

1 reference

12 December 2020

Intravenous immunoglobulin: adverse effects and safe administration

1 reference

12 December 2020

Natural human antibodies to amyloid beta peptide

1 reference

12 December 2020

Natural antibodies against phosphorylcholine as potential protective factors in SLE.

1 reference

12 December 2020

The use of immunoglobulin therapy for patients undergoing solid organ transplantation: an evidence-based practice guideline.

1 reference

12 December 2020

The steroid-sparing effect of intravenous immunoglobulin in patients with autoimmune diseases

1 reference

12 December 2020

Marked improvement of severe cardiac dysfunction after one course of intravenous immunoglobulin in a patient with systemic lupus erythematosus

1 reference

12 December 2020

Intravenous immunoglobulin therapy for autoimmune diseases

1 reference

12 December 2020

Response of vasculitic peripheral neuropathy to intravenous immunoglobulin.

1 reference

12 December 2020

What is the contents of the magic draft IVIg?

1 reference

12 December 2020

Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology

1 reference

12 December 2020

Intravenous immunoglobulin and cytokines: focus on tumor necrosis factor family members BAFF and APRIL.

1 reference

12 December 2020

Anti-idiotypes against antiphospholipid antibodies are present in normal polyspecific immunoglobulins for therapeutic use

1 reference

12 December 2020

Low dose intravenous immunoglobulin in systemic lupus erythematosus: analysis of 62 cases.

1 reference

12 December 2020

Toward molecular targeting with specific intravenous immunoglobulin preparation

1 reference

12 December 2020

Successful treatment of psychosis secondary to SLE with high dose intravenous immunoglobulin

1 reference

12 December 2020

Intravenous immunoglobulin therapy and systemic lupus erythematosus

1 reference

12 December 2020

IVIg therapy in autoimmunity and related disorders: our experience with a large cohort of patients

1 reference

12 December 2020

A study of 20 SLE patients with intravenous immunoglobulin--clinical and serologic response

1 reference

12 December 2020

IV immunoglobulin in patients with myasthenia gravis: a randomized controlled trial

1 reference

12 December 2020

Modulation of the cellular immune system by intravenous immunoglobulin

1 reference

12 December 2020

Differences between IGIV products: impact on clinical outcome

1 reference

12 December 2020

Natural antibodies, intravenous immunoglobulin and their role in autoimmunity, cancer and inflammation

1 reference

12 December 2020

Hypogammaglobulinemia 31 years after the diagnosis of systemic lupus erythematosus

1 reference

12 December 2020

Intravenous immunoglobulin therapy of antiphospholipid syndrome

1 reference

12 December 2020